方法：回顾2010-10/2014-06在我院行有晶状体眼后房型人工晶状体植入术的患者160例310眼，分析其裸眼视力(UCVA)、最佳矫正视力(BCVA)、屈光度、眼压、角膜内皮计数等指标及并发症情况。

结果：视力和屈光度显著改善且稳定。术后UCVA>0.8的有86%，BCVA未见下降，11%比术前提高1行，68%比术前提高≥2行； 96%眼的实际屈光度数稳定在预期的±1.00D。有晶状体眼后房型人工晶状体(ICL)植入术后1h有14眼眼压升高，均未超过28mmHg，术中晶状体损失1眼行透明晶状体摘除及人工晶状体植入； 术后有晶状体眼后房型环曲面人工晶状体(TICL)旋转1眼，术后视网膜脱离3眼，黄斑出血1眼。

结论：有晶状体眼后房型人工晶状体植入术矫治高度近视安全、有效，可预测性高，并发症少，患者满意度高，值得推广，其远期并发症有待进一步观察。

METHODS:The 160 cases with 310 eyes accepted ICL/TICL from October 2010 to June 2014 in our hospital were involved in the study. The uncorrected visual acuity(UCVA), best corrected visual acuity(BCVA), refractive state, intraocular pressure(IOP), corneal endothelial counting and complications were analyzed.

RESULTS:The visual acuity and refractive error were significantly improved and the improvement remained stable. The postoperative UCVA was >0.8 in 86% eyes. No decline of BCVA was observed with 11% increased by 1 line and 68% increased ≥2 lines. The actual refractive state of 96% eyes was ±1.00D around the expected degree. The IOP in 14 eyes increased, but was below 28mmHg at 1h after surgeries. One eye was performed intraocular lens implantation and lens extraction after the lens injury. There were 1 eye with rotation, 3 retinal detachments, and 1 macular hemorrhage after surgeries.

CONCLUSION: ICL/TICL implantation to correct high myopia is effective and safe with high satisfaction, and is worthy of promotion. Its long-term complications need further observation.